Patents by Inventor Dania Rabah

Dania Rabah has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PHARMACEUTICAL COMPOSITIONS AND DOSAGE REGIMENS FOR CLINICAL USE OF ANTI-BLOOD DENDRITIC CELL ANTIGEN 2 ANTIBODIES
    Publication number: 20190284281
    Abstract: Formulations and dosage regimens of anti-Blood Dendritic Cell Antigen 2 (BDCA2) antibodies are provided. These formulations and dosage regimens find use in the treatment of BDCA2-associated disorders such as systematic lupus erythematosus, cutaneous lupus eiythernatosus, and discoid lupus erythematosus, and cytokine release syndrome.
    Type: Application
    Filed: April 27, 2017
    Publication date: September 19, 2019
    Applicant: Biogen MA Inc.
    Inventors: Mark R.H. Krebs, David Dai, Shantanu Sule, Dania Rabah, David Martin